Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01111682 · ClinicalTrials.gov registry record · Phase 3

Hypertonic Saline vs. Mannitol for Elevated Intercranial Pressure

A Phase 3 study, sponsored by University of Cincinnati.

Terminated
Registry status
Phase 3
Development phase
5
Enrollment target

NCT01111682 is a Phase 3 study that was terminated before completion, run by University of Cincinnati. The registered enrollment target is 5 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01111682, a Phase 3 study, was terminated before completion, sponsored by University of Cincinnati.

TERMINATED
Registry status
Phase 3
Development phase
5 participants
Enrollment target

Study Summary

This study examines the role of osmotic agents in controlling brain swelling in brain injured individuals. Two osmotic agents -- mannitol and hypertonic saline -- are in common use, and they will be compared in the context of a randomized clinical trial. The goal is to determine if these agent differ in their ability to control episodes of brain swelling.

Interventions

  • DRUG Mannitol
  • DRUG Hypertonic Saline

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2010-04
Est. Completion 2010-11
Phase Phase 3

Sponsor

University of Cincinnati

245 total trials

What the Registry Record Tells You About NCT01111682

The ClinicalTrials.gov registry entry for NCT01111682 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Mannitol is the first listed.

NCT01111682 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01111682 about?

NCT01111682 is a clinical study titled "Hypertonic Saline vs. Mannitol for Elevated Intercranial Pressure". This study examines the role of osmotic agents in controlling brain swelling in brain injured individuals. Two osmotic agents -- mannitol and hypertonic saline -- are in common use, and they will be compared in the context of a randomized clinical trial. The goal is to determine if these agent diffe...

What is the current status of trial NCT01111682?

This trial is currently terminated. It is a Phase 3 study. The enrollment target is 5 participants. The study started on 2010-04. Estimated completion is 2010-11.

What interventions are being tested in trial NCT01111682?

The interventions under investigation include: Mannitol (DRUG), Hypertonic Saline (DRUG).

Who is sponsoring clinical trial NCT01111682?

This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.